Abstract |
|
Authors | Jeffrey B Rosen, Jose G Jimenez, Valdis Pirags, Hella Vides, Mary E Hanson, Rachid Massaad, Gail McPeters, Philippe Brudi, Joseph Triscari |
Journal | Diabetes & vascular disease research
(Diab Vasc Dis Res)
Vol. 10
Issue 3
Pg. 277-86
(May 2013)
ISSN: 1752-8984 [Electronic] England |
PMID | 23288881
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anticholesteremic Agents
- Azetidines
- Cholesterol, LDL
- Drug Combinations
- Ezetimibe, Simvastatin Drug Combination
- Fluorobenzenes
- Heptanoic Acids
- Pyrimidines
- Pyrroles
- Sulfonamides
- Rosuvastatin Calcium
- Atorvastatin
- Simvastatin
|
Topics |
- Aged
- Aged, 80 and over
- Anticholesteremic Agents
(administration & dosage, adverse effects, therapeutic use)
- Atorvastatin
- Azetidines
(adverse effects, therapeutic use)
- Cardiovascular Diseases
(etiology, prevention & control)
- Cholesterol, LDL
(blood)
- Diabetes Complications
(blood, drug therapy, physiopathology)
- Diabetic Angiopathies
(etiology, prevention & control)
- Double-Blind Method
- Drug Combinations
- Drug Monitoring
- Ezetimibe, Simvastatin Drug Combination
- Female
- Fluorobenzenes
(adverse effects, therapeutic use)
- Heptanoic Acids
(administration & dosage, adverse effects, therapeutic use)
- Humans
- Hypercholesterolemia
(blood, complications, drug therapy, physiopathology)
- Longitudinal Studies
- Male
- Middle Aged
- Pyrimidines
(adverse effects, therapeutic use)
- Pyrroles
(administration & dosage, adverse effects, therapeutic use)
- Rosuvastatin Calcium
- Severity of Illness Index
- Simvastatin
(administration & dosage, adverse effects, therapeutic use)
- Sulfonamides
(adverse effects, therapeutic use)
|